These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1078 related items for PubMed ID: 18440693

  • 1. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [Abstract] [Full Text] [Related]

  • 2. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
    Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK.
    Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
    [Abstract] [Full Text] [Related]

  • 3. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
    Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK.
    Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T, Farrant C, Wise MR.
    Cochrane Database Syst Rev; 2020 Sep 06; 9(9):CD012658. PubMed ID: 32909630
    [Abstract] [Full Text] [Related]

  • 6. Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study.
    Scarselli G, Bargelli G, Taddei GL, Marchionni M, Peruzzi E, Pieralli A, Mattei A, Buccoliero AM, Fambrini M.
    Fertil Steril; 2011 Jan 06; 95(1):420-2. PubMed ID: 20723889
    [Abstract] [Full Text] [Related]

  • 7. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women.
    Hampton NR, Rees MC, Lowe DG, Rauramo I, Barlow D, Guillebaud J.
    Hum Reprod; 2005 Sep 06; 20(9):2653-60. PubMed ID: 15905289
    [Abstract] [Full Text] [Related]

  • 8. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia<sup/>.
    Marnach ML, Butler KA, Henry MR, Hutz CE, Langstraat CL, Lohse CM, Casey PM.
    J Womens Health (Larchmt); 2017 Apr 06; 26(4):368-373. PubMed ID: 27901412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
    Abu Hashim H, Ghayaty E, El Rakhawy M.
    Am J Obstet Gynecol; 2015 Oct 06; 213(4):469-78. PubMed ID: 25797236
    [Abstract] [Full Text] [Related]

  • 12. Long-term use of the levonorgestrel-releasing intrauterine system.
    Inki P.
    Contraception; 2007 Jun 06; 75(6 Suppl):S161-6. PubMed ID: 17531611
    [Abstract] [Full Text] [Related]

  • 13. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
    Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, Lee JH, Ju W, Song ES, Park H, Ryu HS, Lee C, Kang SB.
    Int J Gynecol Cancer; 2016 May 06; 26(4):711-5. PubMed ID: 26905333
    [Abstract] [Full Text] [Related]

  • 14. Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia.
    Ewies AA, Alfhaily F.
    Obstet Gynecol Surv; 2012 Nov 06; 67(11):726-33. PubMed ID: 23151756
    [Abstract] [Full Text] [Related]

  • 15. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.
    Buttini MJ, Jordan SJ, Webb PM.
    Aust N Z J Obstet Gynaecol; 2009 Jun 06; 49(3):316-22. PubMed ID: 19566568
    [Abstract] [Full Text] [Related]

  • 16. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM, Hidalgo-Regina C, Bahamondes MV, Monteiro I, Petta CA, Bahamondes L.
    Contraception; 2009 Jul 06; 80(1):84-9. PubMed ID: 19501221
    [Abstract] [Full Text] [Related]

  • 17. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N.
    Cochrane Database Syst Rev; 2018 Dec 04; 12(12):CD009458. PubMed ID: 30521671
    [Abstract] [Full Text] [Related]

  • 18. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
    Ørbo A, Arnes M, Hancke C, Vereide AB, Pettersen I, Larsen K.
    Gynecol Oncol; 2008 Oct 04; 111(1):68-73. PubMed ID: 18684496
    [Abstract] [Full Text] [Related]

  • 19. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
    Haimovich S, Checa MA, Mancebo G, Fusté P, Carreras R.
    Menopause; 2008 Oct 04; 15(5):1002-4. PubMed ID: 18451744
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.